Zimmer Biomet Holdings, Inc. Stock Analysis & AI Score
Zimmer Biomet Holdings, Inc. (ZBH) has an ST Score of 55.7 (B-), driven by its Profitability (A) and held back by its Valuation (D+). Analysts rate it Hold with a $103.11 price target (+15.0% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Zimmer Biomet Holdings, Inc. (ZBH) has an ST Score of 55.7 (B-), driven by its Profitability (A) and held back by its Valuation (D+). Analysts rate it Hold with a $103.11 price target (+15.0% upside).
- Strongest
- ProfitabilityA
- Weakest
- ValuationD+
All factor grades
- ProfitabilityA
- MomentumB+
- GrowthC+
- Financial StrengthC
- ForecastC
- ValuationD+
- Piotroski7/9
Contact
ZBH stock: frequently asked questions
What is ZBH's ST Score?
Zimmer Biomet Holdings, Inc. (ZBH) has an ST Score of 55.7 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ZBH a buy, hold, or sell?
Analysts rate ZBH a Hold, with a price target of $103.11 (+15.0% vs the current price). Our ST Score grades it B- (55.7/100). The ST Score is a data-driven signal, not a recommendation.
What are ZBH's factor grades?
Valuation D+, Profitability A, Financial Strength C, Momentum B+, Growth C+, Forecast C.
What is ZBH's valuation grade?
Zimmer Biomet Holdings, Inc. (ZBH) earns a valuation grade of D+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ZBH's growth grade?
Zimmer Biomet Holdings, Inc. (ZBH) earns a growth grade of C+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ZBH's profitability grade?
Zimmer Biomet Holdings, Inc. (ZBH) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ZBH's financial strength grade?
Zimmer Biomet Holdings, Inc. (ZBH) earns a financial strength grade of C, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ZBH?
The average analyst price target for Zimmer Biomet Holdings, Inc. (ZBH) is $103.11 from 42 analysts, which is +15.0% versus the recent price of $89.69.
What is ZBH's Piotroski score?
Zimmer Biomet Holdings, Inc. (ZBH) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.